594 related articles for article (PubMed ID: 8639078)
1. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1993 Sep; 111(9):1189-99. PubMed ID: 7689826
[TBL] [Abstract][Full Text] [Related]
3. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993
[TBL] [Abstract][Full Text] [Related]
4. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
Atebara NH; Thomas MA; Holekamp NM; Mandell BA; Del Priore LV
Ophthalmology; 1998 Sep; 105(9):1598-605. PubMed ID: 9754163
[TBL] [Abstract][Full Text] [Related]
5. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
[TBL] [Abstract][Full Text] [Related]
6. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
[TBL] [Abstract][Full Text] [Related]
7. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1993 Sep; 111(9):1200-9. PubMed ID: 7689827
[TBL] [Abstract][Full Text] [Related]
8. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis.
Berger AS; Conway M; Del Priore LV; Walker RS; Pollack JS; Kaplan HJ
Arch Ophthalmol; 1997 Aug; 115(8):991-6. PubMed ID: 9258220
[TBL] [Abstract][Full Text] [Related]
9. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1994 Apr; 112(4):489-99. PubMed ID: 7512335
[TBL] [Abstract][Full Text] [Related]
10. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial.
Bressler NM; Maguire MG; Murphy PL; Alexander J; Margherio R; Schachat AP; Fine SL; Stevens TS; Bressler SB
Arch Ophthalmol; 1996 Dec; 114(12):1456-64. PubMed ID: 8953976
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1997 Jun; 115(6):741-7. PubMed ID: 9194725
[TBL] [Abstract][Full Text] [Related]
12. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
[TBL] [Abstract][Full Text] [Related]
13. Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group.
; Solomon SD; Jefferys JL; Hawkins BS; Bressler NM
Arch Ophthalmol; 2007 Oct; 125(10):1323-30. PubMed ID: 17923538
[TBL] [Abstract][Full Text] [Related]
14. Argon green vs krypton red laser photocoagulation for extrafoveal choroidal neovascularization. One-year results in ocular histoplasmosis. The Canadian Ophthalmology Study Group.
Arch Ophthalmol; 1994 Sep; 112(9):1166-73. PubMed ID: 7522003
[TBL] [Abstract][Full Text] [Related]
15. Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. The Choroidal Neovascularization Prevention Trial Research Group.
Ophthalmology; 1998 Aug; 105(8):1364-72. PubMed ID: 9709744
[TBL] [Abstract][Full Text] [Related]
16. Photocoagulation of well-defined choroidal neovascularization in age-related macular degeneration: clinicopathologic correlation.
Schneider S; Greven CM; Green WR
Retina; 1998; 18(3):242-50. PubMed ID: 9654416
[TBL] [Abstract][Full Text] [Related]
17. Indirect scatter laser photocoagulation to subfoveal choroidal neovascularization in age-related macular degeneration.
Arnold J; Algan M; Soubrane G; Coscas G; Barreau E
Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):208-16. PubMed ID: 9143888
[TBL] [Abstract][Full Text] [Related]
18. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.
Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.
Arch Ophthalmol; 1994 Sep; 112(9):1176-84. PubMed ID: 7522004
[TBL] [Abstract][Full Text] [Related]
20. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9.
Hawkins BS; Bressler NM; Bressler SB; Davidorf FH; Hoskins JC; Marsh MJ; Miskala PH; Redford M; Sternberg P; Thomas MA; Toth CA;
Arch Ophthalmol; 2004 Nov; 122(11):1597-611. PubMed ID: 15534121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
